Chris Brinsmead

chris.jpg

Chris Brinsmead worked in the Pharmaceutical industry for over thirty years, holding executive leadership roles with ICI. These included leading the commercialisation of a range of cancer medicines, management of the ICI Pharma businesses in Asia and as President and Chair of AstraZeneca UK.  He was President of the ABPI from 2008 to 2010.  Since 2010 he has been a non executive director on several boards including UDG plc, Domino Printing Sciences plc and the Wesleyan Assurance Society. He chairs two private companies, Proveca Ltd and Bamburgh Capital Ltd and recently joined the board of Cambian group plc.  Chris is a Member of Council at Imperial College and an advisor and champion on Life Sciences for the UK Government. He was appointed a CBE in January 2015.